These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2065942

  • 1. [Putrescine in evaluation of the leukemic process in children].
    Kovtunova ME, Riabova TI.
    Gematol Transfuziol; 1991 Jan; 36(1):26-8. PubMed ID: 2065942
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pathomorphosis of acute leukemia].
    Popov VM.
    Sov Med; 1991 Jan; (9):15-8. PubMed ID: 1724709
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow polyamines in children with acute leukemia as related to remission status, therapy, and cellularity of specimens.
    Miale TD, Rennert OM, Lawson DL, Shukla JB, Frias JL.
    Med Pediatr Oncol; 1977 Jan; 3(3):209-30. PubMed ID: 284165
    [Abstract] [Full Text] [Related]

  • 5. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V, Hajdúch M, Dusek J, Jarosová M, Weigl E, Pikalová Z, Indrák K, Safárová M, Janostáková A.
    Neoplasma; 1997 Jan; 44(2):133-6. PubMed ID: 9201294
    [Abstract] [Full Text] [Related]

  • 6. Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
    Geller RB, Larson RA.
    Curr Opin Oncol; 1991 Feb; 3(1):30-8. PubMed ID: 2043696
    [Abstract] [Full Text] [Related]

  • 7. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M, Matysiak M, Newecka-Samól T, Kulus M, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Jackowska T, Jakowicka M.
    Pol Tyg Lek; 1991 Feb; 47(16-17):350-3. PubMed ID: 1437752
    [Abstract] [Full Text] [Related]

  • 8. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M, Hohenlöchter B, Schulze-Westhoff P, Zimmermann M, Ritter J, Jürgens H, Boos J.
    Klin Padiatr; 1996 Feb; 208(4):151-9. PubMed ID: 8926681
    [Abstract] [Full Text] [Related]

  • 9. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y, Ito R, Saito T, Suto Y, Tateoka N, Onodera N, Ikeda Y, Ito E, Miyano T, Tachibana N.
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of children with recurrent acute lymphoblastic leukemia].
    Sotnikova NI.
    Pediatriia; 1989 Nov; (4):62-5. PubMed ID: 2734065
    [No Abstract] [Full Text] [Related]

  • 11. FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.
    Mustafa O, Abdalla K, AlAzmi AA, Elimam N, Abrar MB, Jastaniah W.
    J Oncol Pharm Pract; 2019 Dec; 25(8):1831-1838. PubMed ID: 30518307
    [Abstract] [Full Text] [Related]

  • 12. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [Abstract] [Full Text] [Related]

  • 13. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
    Komada Y, Azuma E, Yamamoto H, Tanaka S, Shimizu K, Kamiya H, Sakurai M, Izawa T.
    Biomed Pharmacother; 1988 May; 42(9):597-603. PubMed ID: 3240364
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

  • 15. Acute leukemia in children.
    Kastan MB, Civin CI.
    Curr Opin Oncol; 1990 Feb 15; 2(1):34-40. PubMed ID: 2095231
    [No Abstract] [Full Text] [Related]

  • 16. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.
    J Pediatr Hematol Oncol; 2001 Dec 15; 23(9):591-7. PubMed ID: 11902303
    [Abstract] [Full Text] [Related]

  • 17. [Acute leukemia in childhood].
    Fink FM, Gadner H.
    Wien Med Wochenschr; 1991 Dec 15; 141(9-10):190-5. PubMed ID: 1949840
    [Abstract] [Full Text] [Related]

  • 18. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
    Steinherz PG, Shukla N, Kobos R, Steinherz L.
    Pediatr Blood Cancer; 2010 May 15; 54(5):687-93. PubMed ID: 20205253
    [Abstract] [Full Text] [Related]

  • 19. [State of stromal microenvironment of the bone marrow during remission of acute lymphoblastic leukemia in children].
    Egamberdiev O.
    Pediatriia; 1991 May 15; (11):50-4. PubMed ID: 1766741
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometry DNA measurement for prediction of effect of therapy in acute leukemia.
    Zhang RX, Yao EG.
    J Tongji Med Univ; 1990 May 15; 10(3):181-6. PubMed ID: 2255007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.